Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

NCT04051047 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Withdrawn by Principal Investigator

Conditions

Interventions

Sponsor

University of Michigan Rogel Cancer Center

Collaborators